Literature DB >> 29567587

Clinical and laboratory characteristics of isolated lupus anticoagulants.

E Mattia1, M Tonello1, T Del Ross1, P Zerbinati2, E Campello2, P Simioni2, A Ruffatti3.   

Abstract

Keywords:  Activated Partial Thromboplastin Time; Antiphospholipid syndrome; Diluted Russell's viper venom time; Lupus anticoagulants; Silica clotting time

Mesh：

Substances：

Year:  2018        PMID： 29567587     DOI： 10.1016/j.thromres.2018.03.008

Source DB:  PubMed          Journal:  Thromb Res        ISSN： 0049-3848            Impact factor:   3.944


× No keyword cloud information.
  5 in total

Review 1.  Laboratory Diagnosis of Antiphospholipid Syndrome: Insights and Hindrances.

Authors:  Arne Vandevelde; Katrien M J Devreese
Journal:  J Clin Med       Date:  2022-04-13       Impact factor: 4.964

2.  Triple Antiphospholipid (aPL) Antibodies Positivity Is Associated With Pregnancy Complications in aPL Carriers: A Multicenter Study on 62 Pregnancies.

Authors:  Maria-Grazia Lazzaroni; Micaela Fredi; Laura Andreoli; Cecilia Beatrice Chighizola; Teresa Del Ross; Maria Gerosa; Anna Kuzenko; Maria-Gabriella Raimondo; Andrea Lojacono; Francesca Ramazzotto; Sonia Zatti; Laura Trespidi; Pier-Luigi Meroni; Vittorio Pengo; Amelia Ruffatti; Angela Tincani
Journal:  Front Immunol       Date:  2019-08-14       Impact factor: 7.561

3.  Role of antiphospholipid antibodies in the diagnosis of antiphospholipid syndrome.

Authors:  Katrien M J Devreese; Stéphane Zuily; Pier Luigi Meroni
Journal:  J Transl Autoimmun       Date:  2021-11-06

4.  Systematic Review of Antiphospholipid Antibodies in COVID-19 Patients: Culprits or Bystanders?

Authors:  Thomas Foret; Virginie Dufrost; Lucie Salomon Du Mont; Patricia Costa; Benjamin Lefevre; Patrick Lacolley; Veronique Regnault; Stephane Zuily; Denis Wahl
Journal:  Curr Rheumatol Rep       Date:  2021-07-03       Impact factor: 4.592

5.  Antiphospholipid antibodies in patients with COVID-19: A relevant observation?

Authors:  Katrien M J Devreese; Eleni A Linskens; Dominique Benoit; Harlinde Peperstraete
Journal:  J Thromb Haemost       Date:  2020-07-23       Impact factor: 16.036
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.